Regulatory Open Forum

 View Only
Reg Intel Conference 2024
Back to discussions
Expand all | Collapse all

Discribing fotostability in module 3 for drugs from human plasma (e.g. immunoglobulin)

  • 1.  Discribing fotostability in module 3 for drugs from human plasma (e.g. immunoglobulin)

    This message was posted by a user wishing to remain anonymous
    Posted 26-May-2021 07:45
    This message was posted by a user wishing to remain anonymous

    Hello RAC community,

    I have a question about evaluation of photostability for drugs from human plasma (e.g. immunoglobulin).
    Does biotechnological/biological products need evaluation of photostability in module 3 ?
    If not, what data should be representative or not .


Related Content